{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:33:36Z","timestamp":1759484016656,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.acuro.2019.08.003","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T09:26:48Z","timestamp":1576747608000},"page":"148-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["La resonancia magn\u00e9tica como herramienta para el diagn\u00f3stico del c\u00e1ncer de pr\u00f3stata: nuevas evidencias y posicionamiento de la ESUT (EAU Section of Uro-Technology)"],"prefix":"10.1016","volume":"44","author":[{"given":"M.","family":"\u00c1lvarez-Maestro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"G\u00f3mez Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Quesada Olarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.M.","family":"Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Trelles Guzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Aguilera Baz\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mart\u00ednez-Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Liatsikos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Barret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuro.2019.08.003_bib0225","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1464-410X.2012.11513.x","article-title":"Critical role of prostate biopsy mortality in the number of years of life gained and lost within a prostate cancer screening programme","volume":"110","author":"Boniol","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.acuro.2019.08.003_bib0230","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0235","unstructured":"Mottet N, van den Bergh RCN, Briers E, Cornford P, de Santis M, Fanti S, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent. European Association of Urology Guidelines; 2019."},{"key":"10.1016\/j.acuro.2019.08.003_bib0240","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0022-5347(05)00957-2","article-title":"Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: A systematic review","volume":"175","author":"Hempel","year":"2006","journal-title":"J Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0245","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1464-410X.2012.11072.x","article-title":"Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: Report from a consensus panel","volume":"110","author":"Smeenge","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2019.08.003_bib0250","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-5347(17)38663-9","article-title":"Ultrasound guided transrectal core biopsies of the palpably abnormal prostate","volume":"142","author":"Hodge","year":"1989","journal-title":"J Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0255","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.eururo.2008.03.049","article-title":"Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: The Lahey Clinic Medical Center experience and an international meta-analysis","volume":"54","author":"Cohen","year":"2008","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0260","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.eururo.2015.01.013","article-title":"Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature","volume":"68","author":"F\u00fctterer","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0265","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1148\/radiology.154.1.2578070","article-title":"Magnetic resonance imaging of the prostate","volume":"154","author":"Poon","year":"1985","journal-title":"Radiology."},{"key":"10.1016\/j.acuro.2019.08.003_bib0270","unstructured":"National Institute for Health and Care Excellence. Prostate cancer: Diagnosis and management. NICE guideline [NG131]. NICE; 2019. Disponible en: https:\/\/www.nice.org.uk\/guidance\/ng131\/chapter\/Recommendations#assessment-and-diagnosis"},{"key":"10.1016\/j.acuro.2019.08.003_bib0275","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer. NCCN; 2019. Disponible en: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf"},{"key":"10.1016\/j.acuro.2019.08.003_bib0280","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.eururo.2017.02.026","article-title":"What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis from the European Association of Urology Prostate Cancer guidelines panel","volume":"72","author":"Moldovan","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0285","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.juro.2013.04.119","article-title":"Early detection of prostate cancer: AUA guideline","volume":"190","author":"Carter","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0290","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41391-018-0071-8","article-title":"MRI in prostate cancer diagnosis: Do we need to add standard sampling? A review of the last 5 years","volume":"21","author":"Stabile","year":"2018","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.acuro.2019.08.003_bib0295","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s00330-013-2795-0","article-title":"Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: A prospective study","volume":"23","author":"Bratan","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0300","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.eururo.2015.01.013","article-title":"Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature","volume":"68","author":"Futterer","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0305","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.eururo.2016.08.041","article-title":"Diagnostic pathway with multiparametric magnetic resonance imaging versus standard pathway: Results from a randomized prospective study in biopsy-naive patients with suspected prostate cancer","volume":"72","author":"Porpiglia","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0310","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): A paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.acuro.2019.08.003_bib0315","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.anndiagpath.2015.10.013","article-title":"Outcomes of Gleason score 3+4=7 prostate cancer with minimal amounts (<6%) vs\u22656% of Gleason pattern 4 tissue in needle biopsy specimens","volume":"20","author":"K\u0131r","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0320","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/bju.13333","article-title":"Gleason pattern 4: Active surveillance no more","volume":"117","author":"Sathianathen","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.acuro.2019.08.003_bib0325","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.juro.2015.10.140","article-title":"The diagnostic performance of multiparametric magnetic resonance imaging to detect significant prostate cancer","volume":"195","author":"Thompson","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0330","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acuro.2019.08.003_bib0335","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.eururo.2015.03.041","article-title":"A randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy","volume":"69","author":"Baco","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0340","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.eururo.2015.05.024","article-title":"Prebiopsy multiparametric magnetic resonance imaging for prostate cancer diagnosis in biopsy naive men with suspected prostate cancer based on elevated prostate-specific antigen values: Results from a randomized prospective blinded controlled trial","volume":"69","author":"Tonttila","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0345","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.eururo.2014.03.002","article-title":"Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies","volume":"66","author":"Pokorny","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0350","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/cncr.29874","article-title":"Prostate cancer detection with magnetic resonance ultrasound fusion biopsy: The role of systematic and targeted biopsies","volume":"122","author":"Filson","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.acuro.2019.08.003_bib0355","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): A prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0360","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"Van der Leest","year":"2019","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0365","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.eururo.2013.03.030","volume":"64","author":"Moore","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuro.2019.08.003_bib0370","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.eururo.2016.06.011","article-title":"Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: The PRECISE recommendations\u2013A report of a European school of oncology task force","volume":"71","author":"Moore","year":"2017","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0375","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.euf.2018.02.012","article-title":"Prostate indeterminate lesions on magnetic resonance imaging-biopsy versus surveillance: A literature review","volume":"5","author":"G\u00f3mez Rivas","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.acuro.2019.08.003_bib0380","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.crad.2019.05.019","article-title":"PI-RADS version 2.1: One small step for prostate MRI","volume":"74","author":"Barrett","year":"2019","journal-title":"Clin Radiol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0385","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.eururo.2014.10.050","article-title":"Magnetic resonance imaging in active surveillance of prostate cancer: A systematic review","volume":"67","author":"Schoots","year":"2015","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0395","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2018.11.040","article-title":"The FUTURE Trial: A multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies","volume":"75","author":"Wegelin","year":"2019","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0400","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.eururo.2019.05.029","article-title":"High diagnostic performance of short magnetic resonance imaging protocols for prostate cancer detection in biopsy-na\u00efve men: The next step in magnetic resonance imaging accessibility","volume":"76","author":"Van der Leest","year":"2019","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0405","first-page":"1011","article-title":"Performance comparison of 1.5T endorectal coil MRI with non-endorectal coil 3.0T MRI in patients with prostate cancer","volume":"36","author":"Shah","year":"2016","journal-title":"Acad Radiol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0410","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejrad.2017.02.044","article-title":"Magnetic resonance imaging of the prostate at 1.5 versus 3.0T: A prospective comparison study of image quality","volume":"90","author":"Ullrich","year":"2017","journal-title":"Eur J Radiol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0415","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.juro.2014.01.014","article-title":"Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: A prospective study","volume":"192","author":"Thompson","year":"2014","journal-title":"J Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0420","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate imaging\u2013Reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2015","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0425","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5534\/wjmh.180025","article-title":"The use of magnetic resonance imaging in the prostate cancer primary diagnostic pathway: Is it ready for primetime?","volume":"36","author":"Sathianathen","year":"2018","journal-title":"World J Mens Health"},{"key":"10.1016\/j.acuro.2019.08.003_bib0430","article-title":"Multiparametric MRI for prostate cacer diagnosis: Current status and future directions","author":"Stabile","year":"2019","journal-title":"Nat Rev Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0435","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.eururo.2013.12.012","article-title":"Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: A modelling study from a health care perspective","volume":"66","author":"De Rooij","year":"2014","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuro.2019.08.003_bib0440","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.eururo.2015.07.029","article-title":"Accuracy of magnetic resonance imaging for local staging of prostate cancer: A diagnostic meta-analysis","volume":"70","author":"De Rooij","year":"2016","journal-title":"Eur Urol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480619301639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210480619301639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:36:20Z","timestamp":1759322180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210480619301639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0210480619301639"],"URL":"https:\/\/doi.org\/10.1016\/j.acuro.2019.08.003","relation":{},"ISSN":["0210-4806"],"issn-type":[{"type":"print","value":"0210-4806"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La resonancia magn\u00e9tica como herramienta para el diagn\u00f3stico del c\u00e1ncer de pr\u00f3stata: nuevas evidencias y posicionamiento de la ESUT (EAU Section of Uro-Technology)","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2019.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}